P{lacW} insertion in an intron, 255bp upstream of the first coding exon.
Heterozygotes and RyRk04913/RyRGS21220 animals show resistance to halothane compared to wild type.
RyRk04913/RyRGS21220 animals show resistance to sevoflurane, enflurane and isoflurane compared to wild type.
The body wall contraction (BWC) rate of heterozygous larvae on an agar substrate is nearly normal.
Rya-r44Fk04913 young larvae appear normal and die during first and second larval instar stages. A very mild, but reproducible defect in visceral muscle function, as assayed by ingestion, can be seen in mutants.
RyR[+]/RyRk04913 is an enhancer of visible | adult stage phenotype of Hsap\MAPTUAS.cWa, Scer\GAL4GMR.PF
RyR[+]/RyRk04913 is a non-enhancer of partially lethal - majority die phenotype of Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP
RyR[+]/RyRk04913 is a non-suppressor of partially lethal - majority die phenotype of Scer\GAL4elav-C155, cacRQ,SL.UAS.EGFP
Pkd2ko67, RyR[+]/RyRk04913 has abnormal locomotor behavior | larval stage phenotype
RyR[+]/RyRk04913 is an enhancer of eye phenotype of Hsap\MAPTUAS.cWa, Scer\GAL4GMR.PF
RyRGS21220/RyRk04913 is rescued by RyRUAS.Tag:V5/Scer\GAL4nrv2.PS
Expression of RyRScer\UAS.T:SV5\V5 under the control of Scer\GAL4nrv2.PS restores sensitivity to halothane in RyRk04913/RyRGS21220 animals.
Separable from: a closely linked separable lethal mutation (the homozygous lethality of the chromosome is not rescued by RyR+tCH321-24D03).
Phenotypic analysis suggest the allelic series: Df(2R)Np3 > Rya-r44F16 > Rya-r44Fk04913.